MRNA

Moderna Stock Price

216.00
-1.00 (-0.46%)
Upgrade to Real-Time
Afterhours (Closed)
216.00

Low
54.21

52 Week Range

High
227.63

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Moderna Inc MRNA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.00 -0.46% 216.00 00:00:04
Open Price Low Price High Price Close Price Prev Close
211.91 211.80 218.90 218.85 217.00
Bid Price Ask Price Spread News
206.58 249.98 43.40 3 4
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
76,048 5,576,026 $ 215.09 $ 1,199,359,811 9,784,451 54.21 - 227.63
Last Trade Time Type Quantity Stock Price Currency
19:59:53 5 $ 216.00 USD

Moderna Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 86.73B 401.53M 293.40M $ 803.40M $ 175.86M -1.95 175.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -4.69M 5.90%

more financials information »

Moderna News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MRNA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week197.50227.63197.33215.1212,339,12318.509.37%
1 Month150.85227.63150.40191.328,159,29865.1543.19%
3 Months143.06227.63117.3411167.139,480,09572.9450.99%
6 Months159.78227.63102.66149.1012,908,51656.2235.19%
1 Year62.95227.6354.21113.8215,765,072153.05243.13%
3 Years22.00227.6311.5486.849,936,339194.00881.82%
5 Years22.00227.6311.5486.849,936,339194.00881.82%

Moderna Description

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 24 mRNA development programs as of early 2021, with 13 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.


Your Recent History
NASDAQ
MRNA
Moderna
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.